← Open Payments lookup

KATIE MCGILL: Open Payments

NPI 1972912202 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$933 in 45 payments from 18 companies in 2025. Trend: 2023 $527 · 2024 $674 · 2025 $933

Food & beverage: $933
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$305
Insmed, Inc.5$115
JAZZ PHARMACEUTICALS INC.6$103
Viatris Specialty LLC3$47
Regeneron Healthcare Solutions, Inc.3$45
Verona Pharma, Inc.2$37
GENZYME CORPORATION2$35
Novo Nordisk Inc1$34
Merck Sharp & Dohme LLC1$32
Lilly USA, LLC2$29

Products named: TEZSPIRE, FASENRA, Arikayce, XYWAV, DUPIXENT, YUPELRI, Ohtuvayre, Wegovy.

Industry payments across NE — which companies pay providers there.